Canna~Fangled Abstracts Methods to Quantify Cell Signaling and GPCR Receptor Ligand Bias: Characterization of Drugs that Target the Endocannabinoid Receptors in Huntington's Disease. Methods Mol Biol. 2018;1780:549-571. doi: 10.1007/978-1-4939-7825-0_25. Bagher AM1,2, Laprairie RB1,3, Kelly MEM1,4, Denovan-Wright EM5. Author…Freedom WaresJune 2, 2018
Canna~Fangled Abstracts Medical cannabis: aligning use to evidence-based medicine approach. Br J Clin Pharmacol. 2018 Jun 2. doi: 10.1111/bcp.13657. Schleider LB1, Abuhasira R1, Novack V1.…Freedom WaresJune 2, 2018
Canna~Fangled Abstracts Effects of cannabidiol plus naltrexone on motivation and ethanol consumption. Br J Pharmacol. 2018 Jun 2. doi: 10.1111/bph.14380. Viudez-Martínez A1, García-Gutiérrez MS1,2, Fraguas-Sánchez AI3, Torres-Suárez…Freedom WaresJune 2, 2018
Canna~Fangled Abstracts Identification of Synergistic Interaction Between Cannabis-Derived Compounds for Cytotoxic Activity in Colorectal Cancer Cell Lines and Colon Polyps That Induces Apoptosis-Related Cell Death and Distinct Gene Expression. Cannabis Cannabinoid Res. 2018 Jun 1;3(1):120-135. doi: 10.1089/can.2018.0010. eCollection 2018. Nallathambi R1, Mazuz M1, Namdar…Freedom WaresJune 1, 2018
Canna~Fangled Abstracts Hippocampal mammalian target of rapamycin is implicated in stress-coping behavior induced by cannabidiol in the forced swim test. J Psychopharmacol. 2018 Jun 1:269881118784877. doi: 10.1177/0269881118784877. Sartim AG1, Sales AJ2, Guimarães FS2,3,4, Joca SRL1,3,5,4.…Freedom WaresJune 1, 2018
Canna~Fangled Abstracts Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington’s disease. Neuropsychopharmacology. 2018 Jun 1. doi: 10.1038/s41386-018-0107-8. Covey DP1, Dantrassy HM1, Yohn SE2,3, Castro A1, Conn…Freedom WaresJune 1, 2018
Canna~Fangled Abstracts Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease. Neuropsychopharmacology. 2018 Jun 1. doi: 10.1038/s41386-018-0107-8. Covey DP1, Dantrassy HM1, Yohn SE2,3, Castro A1, Conn…Freedom WaresJune 1, 2018
Canna~Fangled Abstracts The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes. Br J Pharmacol. 2018 Jun 1. doi: 10.1111/bph.14382. Fernández-Ruiz J1,2,3. Author information Abstract At the…Freedom WaresJune 1, 2018